Sarepta’s DMD Gene Therapy, Like Exondys 51, Is Foundational, Advocates Argue

 
• By Derrick Gingery
  
foundation
An approval of SRP-9001 will help other gene therapy improvements move forward, CureDuchenne's chief scientific officer said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies